TrialProceedings of the National Academy of Sciences of the United States of America2010

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus.

John DeVincenzo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.